What is Trayt?
Trayt is a patient-centric data analytics company dedicated to enhancing the diagnosis, treatment, and overall quality of life for individuals with autism, ADHD, and other brain disorders. The company develops tools designed to meticulously measure the efficacy of various treatments. By engaging the entire system of care, Trayt aims to continuously track, measure, and share crucial behavioral and medical outcomes, thereby fostering a more informed and effective approach to neurological health.
How much funding has Trayt raised?
Trayt has raised a total of $7.2M across 1 funding round:
Private Equity
$7.2M
Private Equity (2026): $7.2M, investors not publicly disclosed
What's next for Trayt?
The substantial enterprise-level funding indicates Trayt is poised for significant scaling and further development of its innovative data analytics platform. This capital infusion will likely fuel expansion into new markets, enhance research and development efforts, and strengthen strategic partnerships within the healthcare and technology sectors. The company's focus on measurable outcomes suggests a trajectory towards becoming a key player in personalized medicine and digital therapeutics for neurological conditions.
See full Trayt company page
